Upcoming Medical Conferences in BergamoSearch Criteria : Italy Bergamo
Feb 12 - 14, 2020 | EUR €490 | Bergamo, Lombardia
A Matter of Life or Death: Mechanisms, Models and Therapeutic Opportunities is organized by European Association for Cancer Research (EACR) and will be held from Feb 12 - 14, 2020 at Centro Congressi Giovanni XXIII, Bergamo, Lombardia, Italy. Target Audience: The conference aims to bring together scientists from different fields of cancer research with an interest in the role of cell death and its deregulation in cancer initiation, malignant progression, and therapy resistance. The conference will also be of interest to scientists exploiting deregulated cell death pathways, or the consequences of therapy-induced cell death for improving treatment outcome. Given its translational character, the conference is of broad interest for basic scientists, medical and clinician scientists as well as representatives from industry. We will provide various opportunities for early stage basic and translational cancer researchers, and young clinicians to present their work to the international community and to meet experts in the field of cell death research in an inspiring informal atmosphere to share research findings, to build their own network and to establish or strengthen collaborations. Description: Evading programmed cell death is a major hallmark of cancer cells and contributes to tumour progression and therapy resistance. Emerging hallmarks such as metabolic plasticity, genomic instability and an immunosuppressive tumour environment allow the tumours to escape from standard cytotoxic as well as targeted therapies. Thus, understanding the underlying mechanisms in appropriate pre-clinical/clinical models is crucial for the design of more effective combination therapies to avoid treatment failure or tumour recurrence. Building on the strong success of four previous editions, this will be the 5th conference on this topic. Its objective is to cover recent and exciting developments in the field of cancer research that are crucial to our understanding of the multifaceted role of cell death in tumour initiation, progression and therapy response. Topics to be covered: • Basic mechanisms of cell death, e.g. apoptosis, necroptosis, ferroptosis, and autophagy • Senescence • Metabolic reprogramming and therapeutic targeting • Cancer cell plasticity and resistance to cancer therapies • Tumour immunology and microbiota • Therapy-induced immune activation • New combination strategies • Immunotherapy - Opportunities & Challenges Additional details will be posted as soon as they are available.
Mar 26 - 28, 2020 | EUR €950 | Bergamo, Lombardia
Seventh Bergamo Open Rhinoplasty Course is organized by MZ Congressi and will be held from Mar 26 - 28, 2020 at Centro Congressi Giovanni XXIII, Bergamo, Lombardia, Italy. Target Audience: Surgeons of different specialties (Plastic, ENT, Maxillofacial) who wish to enhance their skills in rhinoplasty at all levels of experience. Both beginners and proficient rhinoplasty surgeons will draw benefit from the customizable program and the different educational tracks. Advanced masterclasses are best reserved to proficient rhinoplasty surgeons. After attending the meeting, the attendee should have the tools to achieve the best possible result when performing an open primary or secondary rhinoseptoplasty. Rhinoplasty Society of Europe Annual Meeting March 25, 2020 Giovanni XXIII Congress Center, Bergamo, Italy Cadaver Dissection Workshop March 29, 2020 ICLO Teaching and Research Center, Verona, Italy Objectives: At the end of the course, the attendees should be able to • Fully understand nasal anatomy, including new anatomical concepts related to nasal function and rhinoplasty technique • Correctly analyze common and less common rhinoplasty issues preoperatively • Formulate an adequate pre-surgical plan, so as to achieve consistent and predictable results • Depending on their previous level of experience, appropriately perform the basic steps of open rhinoplasty, as well as a wide variety of current techniques and modifications of varying complexity • Select reproducible, predictable and appropriate algorithms for specific problems in rhinoplasty • Understand current issues in tip and dorsum surgery and master recent related techniques to improve results, including new specific osteotomy/osteoplasty concepts • Understand the indications, concepts and practice of “Preservation Rhinoplasty” under the open approach, including its advantages and complications • Understand the value of new instrumentation in rhinoplasty, including power tools and piezo • Understand, recognize and treat functional issues in rhinoplasty • Understand, prevent, recognize and correct complications • Understand current techniques of varying complexity in secondary rhinoplasty, including use of fascia and rib grafting • Understand and apply the correct indications and practice of medical rhinoplasty.
Apr 17 - 19, 2020 | Bergamo, Lombardia
10th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) is organized by Services Comunicazione Eventi Cultura (CEC) srl / Servizi Comunicazione Eventi Cultura (CEC) s.r.l. and will be held from Apr 17 - 19, 2020 at Bergamo, Lombardia, Italy. Course Description: The aim of ICTHIC is to review the recent advances in the understanding of the pathogenesis, prevention and treatment of thrombotic and hemorrhagic complications in cancer patients, both from the basic and clinical research points of view. Course Topics: • Epidemiology • Thromboprophylaxis in Medical Patients • Treatment of VTE • Thromboprophylaxis in Surgical Patients • Hypercoagulation and Biomarkers • Complement-driven Thrombotic Syndromes • Gender- and Age-related Issues • Hemostasis in Cancer Biology • Molecular Mechanisms of Thrombosis in Cancer • Tumor Cell/Vascular Cell Interactions • Angiogenesis • Inflammation • New Antithrombotic Drugs • Anticoagulation and Cancer Survival • Arterial Thrombosis • Bleeding • Congenital and Acquired Risk Factors • Thrombohemorrhagic Syndromes • Thrombocytopenia in cancer • Antitumor Properties of Antithrombotics • Microparticles • New Assays for Hypercoagulability • Fibrinolysis • Proteases Additional details will be posted as soon as they are available.